Target 6.6Following in weekly chart. Reversal H & S targets are : TP1 : 4.9 TP2 : 6.6 Actually it's broke out the resistance, but I believe it's going to close the gap in the shoulder. The more it drops, the more I'll buy till 3.65. But you can wait for a clear breakout as well. Longby omurdenUpdated 1
Target 25.17Following weekly chart There is a clear cup & handle formation. I mostly follow handle target, so TP 25.17 SL 9.16 - I know it's too far away but technically this is what it is. Longby omurden4
Alfen May Collapse SoonThis chart could be a perfect example of why you should use caution when dealing with a volatile price chart. We’ve seen this with Bitcoin recently: The price goes up in a steady line, maybe in a parabolic fashion, before the trend weakens. A slowing down of a trend is not necessarily bad. For example: the price went up almost 30% between the first and the last sell signal (the ones at the top). However, it is clear that the price is struggling making more convincing highs. However, be cautious when you see this pattern at the top. A slowing down in a trend after the price went up exponentially is bad. That means that the buyers are exhausted. So to come back to this stock. The price went up exponentially, slowed down, went volatile, and now is below the resistance area. This convinces me that the price will go lower sooner or later. With charts like these, you could be looking at a drop of at least 40% to 50% from the current price.Shortby FetchTeam4
LVMH BEARS ARE WAKING UP !"Companies like LVMH have high quality businesses, they compound profits over long periods of time and deliver great returns for shareholders," said Mark Denham, head of European equities at French asset manager Carmignac. "It is true that the ratings of these companies have risen so it becomes slightly more asymmetric, but over the long term earnings compounding is the dominant factor.” Aside from all above the ticket ti get into this market is getting way higher than it's value therefore a drope is both likely and possible. My own personal trade set up is shown on the chart , please feel free to share your comments . Shortby Crocobot1
DSY // Triangle patternThere is a breakdown in the triangle. Targets are determined according to Fibonacci.by aet611
AIR // Pennant formationFalling prices turned upwards by getting approval from 112.68 level.by aet612
CAP //Cup and handleWhile there is a cup-handle formation on the chart, the targets are targeted according to Fibonacci.by aet613
WLN // cup handle formationAlthough there is a cup-handle formation in the graphic, the targets are determined according to Fibonacci.by aet611
TEP // pennant formationAlthough there is a pennant formation on the chart, the targets are determined according to Fibonacci.by aet611
AIRBUS still bullish to expect Hi viewers, AIR technically watched here expecting new bullish push in next periods TP1:123 TP2:126 TP2:129Longby DepaTrading0
today analysis the volume show us the end of trend and the chart may go down and after keep going up Shortby ayoublouzi193
Sanofi S.A. (SAN.pa) bearish scenario:The technical figure Channel Up can be found in the daily chart in the French company Sanofi S.A. (SAN.pa). Sanofi S.A. is a French multinational pharmaceutical and healthcare company. Sanofi engages in the research and development, manufacturing and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines (it is the world's largest producer of the last through its subsidiary Sanofi Pasteur). The Channel Up broke through the support line on 24/01/2023. If the price holds below this level, you can have a possible bearish price movement with a forecast for the next 26 days towards 86.54 EUR. According to experts, your stop-loss order should be placed at 92.90 EUR if you decide to enter this position. French drugmaker Sanofi SA plans to launch a drug for rare bleeding disorder hemophilia A this year, Chief Executive Officer Paul Hudson told CNBC in an interview last week. The U.S. Food and Drug Administration last year accepted the marketing application for the therapy, which is being developed in collaboration with Swedish drugmaker Sobi, and is expected to decide on an approval status by Feb. 28. Hemophilia A is an inherited bleeding disorder in which the blood does not clot normally. About 400 babies are born with this condition every year, although the exact number of people affected is not known, according to government data. Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.Shortby legacyFXofficial0
Potential upward move for BESI; entered previous range BESI price broke resistance (now support) and entered in a range where it traded before. Expecting a significant move up, with a potential pause and maybe reverse at the orange resistance level.Longby V-DAC2
Schneider SU.PA shortNow is optimal time we have raising wedge patern Bear FLAgg in one picture:) We go down :)Shortby Traspe1
OR: wait for a pull-back and then re-enterLike the classical Elliott wave count that is unfolding. The current impulse wave 1 might be matured and one can expect a pull-back to 332 - wave 2. Then the bullish trend will resume up to 470. Technical rating: medium and wait for the price action to develop further.Longby Peet_Serfontein0
Air France KLM (If you believe in mirors)As conditions are geting normal in airlines sector. Things are turninpositive step by step.Longby udegirmenci224
Key levels for SANOFIThe algorithm is showing a very profitable pattern in SANOFI. First, if the price breaks up we have a clear rally until the top of the channel with a tight stop loss slightly below the break point. On the other hand, if the market is moving down, we should see a break to the downside of the channel, then an easy break of the support and the blue line would be the last support before we see a major correction to 83$, where 3 different patterns are pointing out as a clear support area where demand will come back. Good luck!by TopChartPatterns1
Double bottom in Credit AgricoleThe algorithm shows an opportunity to buy credit agricole if the double bottom pattern breaks. The double bottom pattern is a bullish reversal pattern that appears on a chart as two distinct bottoms at roughly the same price level, separated by a peak in between. The pattern is formed when the price of an asset falls to a support level, bounces back up, falls back down to the same support level, and then bounces back up again. This pattern is considered bullish because it suggests that the asset's price may be about to start rising again after a period of decline. One way to trade the double bottom pattern is to wait for the price to break above the peak that separates the two bottoms. This is known as the "breakout." Once the price breaks above the peak, it is a signal to buy the asset. Some traders may also set a stop-loss order below the second bottom, to limit their potential losses in case the price does not continue to rise. So, a possibility is to wait the break of 10,2 level and look to sell in the next area where volume increase and we also find supports & resistances (11,50€). A break of the small black line could also be a great point to buy, but it's not a confirmation of the larger double bottom pattern.Longby TopChartPatternsUpdated 2
Rising triangle in anticipation of accelerated approval of FDAPharming has received acceptance from both the EMA and FDA for the accelerated review of leniolisib. The new drug is anticipated to generate significantly more revenue compared to its current profitable drug Ruconest. While the company has been profitable for the past years, it needed to find new sources of income to be able to grow the value of the company. The end of 23Q1 will be crucial for shareholders, who would love to see acceptance from both EMA and FDA. Targets of 3-5 euro per share are not out of the question. A big spike can be expected, as a lot of people are expected to jump on this ship in case of approval. Based on the rising triangle pattern that has been forming since June 22, the theoretical price target would be 1.90 euro, with a breakout before March 8. For now we would look at reaching prior highs. Target 1: 1.50 euro Target 2: 1.635 euro Target 3: 1.90 euroLongby Ntooj2
PROSUS PRX double bottom target 103.30€ (+44%)Prosus has activated a double bottom pattern that may lead the price to 103.30€ that is +44% from current price. Longby compoundinterest72
Legrand (LR.pa) bearish scenario:The technical figure Channel Up can be found in the daily chart of the French company Legrand (LR.pa). Legrand is a French industrial group. It is one of the world leaders in electrical and digital building infrastructures and connected solutions. Legrand is established in 90 countries and its products are distributed in nearly 180. It generates 85% of its sales internationally. The group has expanded its product range in sustainable development and energy saving technologies, and has developed new products for EV charging/electric vehicles, lighting control and datacenters. The Channel Up broke through the support line on 23/12/2022. If the price holds below this level, you can have a possible bearish price movement with a forecast for the next 17 days towards 71.80 EUR. Your stop-loss order, according to experts, should be placed at 85.88 EUR if you decide to enter this position. Legrand, a world leader in electrical, digital infrastructure and connected solutions, has announced its acquisition of Encelium, an Ontario, Canada-based manufacturer of advanced commercial lighting controls. The acquisition of Encelium brand and products, which takes effect immediately, comes as part of Legrand's ongoing global strategy to further strengthen its position in the commercial lighting control sector. A leader in this category, Encelium is already an integral component within thousands of buildings, supporting the needs of occupants, tenants, and facilities managers through people-centric lighting and energy efficiency. Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.Shortby legacyFXofficial1
LVMH, retesting supports before a bounce?LVMH stock rallied and gained momentum after forming the Rounding Bottom pattern, now it is been trading in a downtrend channel, and, seems like it is forming it precisely because the price has been rejected by the upper side, so, if it confirmed to be valid, it will continue its way in the channel until the channel tests the last support, and when so, we'll see a great bounce to the previous levels before making new highs. NOTE: DYOR, stay cautious to place STOP LOSSes, and trade your own personality.Shortby Qasawa6